These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19232285)

  • 1. Alterations in the intestinal microbiota and functional bowel symptoms.
    Ringel Y; Carroll IM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):141-50, vii. PubMed ID: 19232285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and microflora.
    Pimentel M; Chang C
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics in the management of functional bowel disorders: promise fulfilled?
    Quigley EM
    Gastroenterol Clin North Am; 2012 Dec; 41(4):805-19. PubMed ID: 23101688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication between gastrointestinal bacteria and the nervous system.
    Bravo JA; Julio-Pieper M; Forsythe P; Kunze W; Dinan TG; Bienenstock J; Cryan JF
    Curr Opin Pharmacol; 2012 Dec; 12(6):667-72. PubMed ID: 23041079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease.
    Whelan K; Quigley EM
    Curr Opin Gastroenterol; 2013 Mar; 29(2):184-9. PubMed ID: 23286925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial-gut interactions in health and disease. Irritable bowel syndrome.
    Verdu EF; Collins SM
    Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):315-21. PubMed ID: 15123072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection, inflammation, and the irritable bowel syndrome.
    Spiller R; Garsed K
    Dig Liver Dis; 2009 Dec; 41(12):844-9. PubMed ID: 19716778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of probiotics in IBS.
    Quigley EM
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiome-gut-brain axis: from bowel to behavior.
    Cryan JF; O'Mahony SM
    Neurogastroenterol Motil; 2011 Mar; 23(3):187-92. PubMed ID: 21303428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Intestinal Microbiota and Irritable Bowel Syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics.
    Madden JA; Hunter JO
    Br J Nutr; 2002 Sep; 88 Suppl 1():S67-72. PubMed ID: 12215182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics.
    Quigley EM
    Gastroenterol Clin North Am; 2007 Sep; 36(3):735-48, xi. PubMed ID: 17950446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.